Private Market View

OrbiMed

Growth equity · New York, New York

AUM
$20.0B
Portfolio companies
88
Recorded deals
1
Last investment

Key facts

  • OrbiMed is a growth equity firm based in New York, New York with 88 tracked portfolio companies.
  • Notable positions include InSilico Medicine Cayman (HKG: 03696), Treeline Biosciences, Mirador Therapeutics, Genfleet (HKG: 02595), Delfi Diagnostics.
  • The team roster lists 87 people.

About OrbiMed

Founded in 1989, OrbiMed is a growth equity firm based in New York. The firm seeks to invest in companies operating in the biopharmaceutical, life sciences, digital health, healthcare services, medical devices, and diagnostic sectors based in Asia, Europe, and North America. This firm is a Registered Investment Adviser (RIA).

Free account
See the whole book
  • ·The book's top 25 — of 88 recorded positions
  • ·Watchlist + alerts for OrbiMed's activity
Create free account
No card required

Portfolio, priced

88 companies · by our current valuations
CompanyValuationRole
InSilico Medicine Cayman (HKG: 03696)$1.7B
Treeline Biosciences$1.3B
Mirador Therapeutics$1.0B
Genfleet (HKG: 02595)$799.7M
Delfi Diagnostics$725.0M
ReCode Therapeutics$700.0M
Merlyn Mind$668.0M
Candid Therapeutics$657.0M
Kartos Therapeutics$650.0M
Iambic$648.0M
Odyssey Therapeutics$638.2M
Avenzo Therapeutics$590.0M
Mimibox$541.5M
Electra Therapeutics$479.0M
BlossomHill Therapeutics$413.1M
+ 73 more companies · a free account shows the top of the book
Team
87 people on record — 87 with verified contacts

Partners, principals, and the people who answer a pitch. Pro members reveal contacts with credits.

See the team →

Frequently asked

What companies does OrbiMed invest in?
OrbiMed has 88 recorded portfolio companies, including InSilico Medicine Cayman (HKG: 03696), Treeline Biosciences, Mirador Therapeutics, Genfleet (HKG: 02595).
What is OrbiMed's AUM?
OrbiMed manages approximately $20.0B in assets.